Literature DB >> 10692317

Conformation, independent of charge, in the R domain affects cystic fibrosis transmembrane conductance regulator channel openings.

J Xie1, J Zhao, P B Davis, J Ma.   

Abstract

The R domain of cystic fibrosis transmembrane conductance regulator (CFTR), when phosphorylated, undergoes conformational change, and the chloride channel opens. We investigated the contribution of R domain conformation, apart from the changes induced by phosphorylation, to channel opening, by testing the effect of the peptidyl-prolyl isomerase, cyclophilin A, on the CFTR channel. When it was applied after the channel had been opened by PKA phosphorylation, cyclophilin A increased the open probability of wild-type CFTR (from P(o) = 0.197 +/- 0.010 to P(o) = 0.436 +/- 0. 029) by increasing the number of channel openings, not open time. Three highly conserved proline residues in the R domain, at positions 740, 750, and 759, were considered as candidate targets for cyclophilin A. Mutations of these prolines to alanines (P3A mutant) resulted in a channel unresponsive to cyclophilin A but with pore properties similar to the wild type, under strict control of PKA and ATP, but with significantly increased open probability (P(o) = 0.577 +/- 0.090) compared to wild-type CFTR, again due to an increase in the number of channel openings and not open time. Mutation of each of the proline residues separately and in pairs demonstrated that all three proline mutations are required for maximal P(o). When P3A was expressed in 293 HEK cells and tested by SPQ assay, chloride efflux was significantly increased compared to cells transfected with wild-type CFTR. Thus, treatments favoring the trans-peptidyl conformation about conserved proline residues in the R domain of CFTR affect openings of CFTR, above and beyond the effect of PKA phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692317      PMCID: PMC1300730          DOI: 10.1016/S0006-3495(00)76685-9

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  27 in total

1.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

2.  Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel.

Authors:  S H Cheng; D P Rich; J Marshall; R J Gregory; M J Welsh; A E Smith
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

3.  Effect of deleting the R domain on CFTR-generated chloride channels.

Authors:  D P Rich; R J Gregory; M P Anderson; P Manavalan; A E Smith; M J Welsh
Journal:  Science       Date:  1991-07-12       Impact factor: 47.728

4.  Generation of cAMP-activated chloride currents by expression of CFTR.

Authors:  M P Anderson; D P Rich; R J Gregory; A E Smith; M J Welsh
Journal:  Science       Date:  1991-02-08       Impact factor: 47.728

5.  Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by negative charge in the R domain.

Authors:  D P Rich; H A Berger; S H Cheng; S M Travis; M Saxena; A E Smith; M J Welsh
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

6.  Phosphorylation of the cystic fibrosis transmembrane conductance regulator.

Authors:  M R Picciotto; J A Cohn; G Bertuzzi; P Greengard; A C Nairn
Journal:  J Biol Chem       Date:  1992-06-25       Impact factor: 5.157

7.  The amino-terminal portion of CFTR forms a regulated Cl- channel.

Authors:  D N Sheppard; L S Ostedgaard; D P Rich; M J Welsh
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

8.  Phosphorylation by cAMP-dependent protein kinase causes a conformational change in the R domain of the cystic fibrosis transmembrane conductance regulator.

Authors:  A M Dulhanty; J R Riordan
Journal:  Biochemistry       Date:  1994-04-05       Impact factor: 3.162

Review 9.  What we know and what we do not know about cystic fibrosis transmembrane conductance regulator.

Authors:  J Ma; P B Davis
Journal:  Clin Chest Med       Date:  1998-09       Impact factor: 2.878

10.  Effect of deletion mutations on the function of CFTR chloride channels.

Authors:  D P Rich; R J Gregory; S H Cheng; A E Smith; M J Welsh
Journal:  Receptors Channels       Date:  1993
View more
  6 in total

Review 1.  The ABC protein turned chloride channel whose failure causes cystic fibrosis.

Authors:  David C Gadsby; Paola Vergani; László Csanády
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

2.  Phosphorylation of CFTR by PKA promotes binding of the regulatory domain.

Authors:  Valerie Chappe; Thomas Irvine; Jie Liao; Alexandra Evagelidis; John W Hanrahan
Journal:  EMBO J       Date:  2005-07-07       Impact factor: 11.598

3.  CFTR with a partially deleted R domain corrects the cystic fibrosis chloride transport defect in human airway epithelia in vitro and in mouse nasal mucosa in vivo.

Authors:  Lynda S Ostedgaard; Joseph Zabner; Daniel W Vermeer; Tatiana Rokhlina; Philip H Karp; Arlene A Stecenko; Christoph Randak; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

4.  Determinants of hepatitis C virus p7 ion channel function and drug sensitivity identified in vitro.

Authors:  Corine StGelais; Toshana L Foster; Mark Verow; Elizabeth Atkins; Colin W G Fishwick; David Rowlands; Mark Harris; Stephen Griffin
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

5.  Computational studies reveal phosphorylation-dependent changes in the unstructured R domain of CFTR.

Authors:  Tamás Hegedus; Adrian W R Serohijos; Nikolay V Dokholyan; Lihua He; John R Riordan
Journal:  J Mol Biol       Date:  2008-03-26       Impact factor: 5.469

6.  The PEST sequence does not contribute to the stability of the cystic fibrosis transmembrane conductance regulator.

Authors:  Eva Y Chen; David M Clarke
Journal:  BMC Biochem       Date:  2002-10-02       Impact factor: 4.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.